Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

SELL
$351.71 - $456.01 $40,094 - $51,985
-114 Reduced 41.76%
159 $0
Q3 2022

Oct 31, 2022

BUY
$412.59 - $563.26 $50,748 - $69,280
123 Added 82.0%
273 $114,000
Q2 2022

Jul 26, 2022

SELL
$463.67 - $597.16 $230,443 - $296,788
-497 Reduced 76.82%
150 $74,000
Q1 2022

Apr 27, 2022

BUY
$524.57 - $735.42 $30,425 - $42,654
58 Added 9.85%
647 $364,000
Q4 2021

Jan 31, 2022

SELL
$708.84 - $794.68 $869,746 - $975,072
-1,227 Reduced 67.57%
589 $445,000
Q3 2021

Nov 03, 2021

SELL
$657.71 - $825.77 $349,901 - $439,309
-532 Reduced 22.66%
1,816 $1.36 Million
Q2 2021

Jul 30, 2021

SELL
$576.64 - $649.04 $1.37 Million - $1.55 Million
-2,383 Reduced 50.37%
2,348 $1.51 Million
Q1 2021

Apr 29, 2021

BUY
$547.01 - $662.35 $984,070 - $1.19 Million
1,799 Added 61.36%
4,731 $2.7 Million
Q4 2020

Jan 28, 2021

SELL
$510.68 - $643.45 $499,445 - $629,294
-978 Reduced 25.01%
2,932 $1.71 Million
Q3 2020

Oct 29, 2020

SELL
$454.43 - $535.6 $399,898 - $471,328
-880 Reduced 18.37%
3,910 $2.02 Million
Q2 2020

Jul 24, 2020

SELL
$334.87 - $493.06 $120,553 - $177,501
-360 Reduced 6.99%
4,790 $2.16 Million
Q1 2020

Apr 29, 2020

SELL
$320.01 - $409.07 $308,489 - $394,343
-964 Reduced 15.77%
5,150 $1.81 Million
Q4 2019

Jan 27, 2020

BUY
$319.73 - $374.2 $610,364 - $714,347
1,909 Added 45.4%
6,114 $2.26 Million
Q3 2019

Oct 28, 2019

BUY
$304.55 - $345.24 $379,469 - $430,169
1,246 Added 42.11%
4,205 $1.4 Million
Q2 2019

Jul 30, 2019

BUY
$286.93 - $312.59 $315,623 - $343,849
1,100 Added 59.17%
2,959 $925,000
Q1 2019

Apr 30, 2019

SELL
$224.3 - $317.41 $44,860 - $63,482
-200 Reduced 9.71%
1,859 $568,000
Q4 2018

Feb 01, 2019

BUY
$220.1 - $309.0 $453,185 - $636,231
2,059 New
2,059 $478,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.53B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.